These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The inhibition by 6-diazo-5-oxo-l-norleucine of glutamine catabolism of the cultured human lymphoblast. Willis RC; Seegmiller JE J Cell Physiol; 1977 Dec; 93(3):375-82. PubMed ID: 22551 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic resurgence of 6-diazo-5-oxo-l-norleucine (DON) through tissue-targeted prodrugs. Novotná K; Tenora L; Slusher BS; Rais R Adv Pharmacol; 2024; 100():157-180. PubMed ID: 39034051 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory Effect of a Glutamine Antagonist on Proliferation and Migration of VSMCs via Simultaneous Attenuation of Glycolysis and Oxidative Phosphorylation. Park HY; Kim MJ; Lee S; Jin J; Lee S; Kim JG; Choi YK; Park KG Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070527 [TBL] [Abstract][Full Text] [Related]
11. A redox-responsive prodrug for tumor-targeted glutamine restriction. Prange CJ; Sayed NYB; Feng B; Goepfert C; Trujillo DO; Hu X; Tang L J Control Release; 2024 Apr; 368():251-264. PubMed ID: 38403173 [TBL] [Abstract][Full Text] [Related]
12. Uptake of glutamine antimetabolites 6-diazo-5-oxo-L-norleucine (DON) and acivicin in sensitive and resistant tumor cell lines. Huber KR; Rosenfeld H; Roberts J Int J Cancer; 1988 May; 41(5):752-5. PubMed ID: 3366493 [TBL] [Abstract][Full Text] [Related]
13. Influence of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analogue, on cartilaginous differentiation in mouse limb buds in vitro. Aydelotte MB; Kochhar DM Differentiation; 1975 Oct; 4(2):73-80. PubMed ID: 1183764 [TBL] [Abstract][Full Text] [Related]
14. We're Not "DON" Yet: Optimal Dosing and Prodrug Delivery of Lemberg KM; Vornov JJ; Rais R; Slusher BS Mol Cancer Ther; 2018 Sep; 17(9):1824-1832. PubMed ID: 30181331 [TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells. Madden MZ; Ye X; Chi C; Fisher EL; Wolf MM; Needle GA; Bader JE; Patterson AR; Reinfeld BI; Landis MD; Hathaway ES; Muka JE; O'Neil RT; Karijolich J; Philip M; Rathmell JC J Immunol; 2023 Aug; 211(4):563-575. PubMed ID: 37341499 [TBL] [Abstract][Full Text] [Related]
16. L-asparaginase and 6-diazo-5-oxo-L-norleucine synergistically inhibit the growth of glioblastoma cells. Ohba S; Hirose Y J Neurooncol; 2020 Feb; 146(3):469-475. PubMed ID: 32020477 [TBL] [Abstract][Full Text] [Related]
17. Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucine. Potter MC; Baxter VK; Mathey RW; Alt J; Rojas C; Griffin DE; Slusher BS J Neurovirol; 2015 Apr; 21(2):159-73. PubMed ID: 25645378 [TBL] [Abstract][Full Text] [Related]
19. Targeting glutamine metabolism rescues mice from late-stage cerebral malaria. Gordon EB; Hart GT; Tran TM; Waisberg M; Akkaya M; Kim AS; Hamilton SE; Pena M; Yazew T; Qi CF; Lee CF; Lo YC; Miller LH; Powell JD; Pierce SK Proc Natl Acad Sci U S A; 2015 Oct; 112(42):13075-80. PubMed ID: 26438846 [TBL] [Abstract][Full Text] [Related]
20. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. Huysentruyt LC; Shelton LM; Seyfried TN Int J Cancer; 2010 Jan; 126(1):65-72. PubMed ID: 19536778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]